Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 temozolomide monotherapy study in elderly temozolomide-sensitive glioblastoma
jRCTs031200438Phase 2Completed
- Start
- Mar 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in glioblastoma (GBM). Primary endpoint: Overall survival. Started Mar 2021; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on jRCTs031200438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200438.